Cleerly makes FDA-cleared AI that analyses coronary CT scans for plaque and narrowing to assess a patient's risk of heart disease. It raised an additional $106 million, led by Insight Partners with Battery Ventures, as an extension of its Series C.
At a glance
| Price from | Custom |
| Best for | Cardiology practices assessing coronary artery disease |
From Cleerly's own website.
What stands out
- Growing insurance coverage
- FDA cleared
Worth knowing
- Depends on CT imaging capacity
- Price not published
How it ranks
Cleerly is ranked 5th of 10 in Best Medical Device Startups Using AI (Lister Score 91.8).
#5 in Best Medical Device Startups Using AI · Lister Score 91.8
AI coronary plaque analysis received a Category I CPT code effective January 2026, following coverage by several Medicare administrative contractors..
| Rank | Best Medical Device Startups Using AI | Score |
|---|---|---|
| 1 | Aidoc | 96.9 |
| 2 | Exo | 95.6 |
| 3 | Eko Health | 94.3 |
| 4 | Viz.ai | 93.1 |
| 5 | Cleerly | 91.8 |
| 6 | Prenuvo | 90.5 |
| 7 | Ultromics | 89.2 |
| 8 | Qure.ai | 87.9 |
| 9 | Anumana | 86.6 |
| 10 | Proprio | 85.3 |
Frequently asked questions
How does Cleerly rank on Lister?
Cleerly is ranked 5th of 10 in Best Medical Device Startups Using AI (Lister Score 91.8).
Appears in
Add this badge to your site
If you work at Cleerly, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.